Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. Merck KGaA
  6. News
  7. Andere Sprachen
    MRK   DE0006599905   659990

MERCK KGAA

(MRK)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über MERCK KGAA
26.11.MERCK - 54% of Europeans consider their current physical health to be good or very good..
25.11.MERCK KGAA : Barclays reste à surpondérer
25.11.OPINIONES DE LOS ANALISTAS DEL DÍA : Melia Hotels, Scandic, Enel, Merck, Tryg, Accord, Val..
24.11.MARKETMIND : Brace for it
23.11.MARKETMIND : Mind the (Europe-U.S.) gap
22.11.OPINIONES DE LOS ANALISTAS DEL DÍA : AXA, Bayer, Merck, Nordex, Subsea, Geberit, Biontech,..
22.11.Coronavirus vs. Black Friday
18.11.Advanz Pharma Names New CEO, CFO
18.11.MERCK KGAA : partenariat dans les diagnostics compagnons
18.11.Merck KGaA and Burning Rock Collaborate on Liquid-biopsy Based CDx Development Using Bu..
17.11.Pfizer Strikes Supply Deal With Merck KGaA, Imugene for Clinical Trial of Gastric Cance..
17.11.Pfizer Strikes Supply Agreement With Imugene, Merck KGaA for Clinical Trial of Gastric ..
17.11.MERCK KGAA : essai de phase 2 en association avec Imugene
17.11.Smile on dollar bulls
17.11.Imugene Announces Clinical Trial Supply Agreement with Merck Kgaa, Darmstadt, Germany a..
17.11.Imugene Enters Clinical Trial Supply Deal with Merck KGaA and Pfizer to Evaluate Gastri..
16.11.MERCK KGAA : résultats positifs pour un anti-parasitaire
16.11.Merck KGaA's Schistosomiasis Drug Meets Primary Efficacy Endpoint in Phase 3 Trial
16.11.Merck KGaA's Schistosomiasis Drug Shows Positive Results in Phase-3 Children Trial
15.11.MARKETMIND : I fought the Fed and the Fed won
12.11.J&J to spin off consumer products and focus on pharmaceuticals
11.11.GLOBAL MARKETS LIVE : Daimler, Delivery Hero, Foxconn, China Evergrande, Kraft Heinz...
11.11.EUROPEAN MIDDAY BRIEFING - Stocks Rise After -2-
11.11.Polymer Factory Sweden AB extends quality agreement with Merck KGaA
11.11.Polymer Factory Sweden AB Extends Quality Agreement with Merck KGaA
11.11.Merck says making progress on meeting surge in lab gear demand
11.11.OPINIONES DE LOS ANALISTAS DEL DÍA : Arcelormittal, Delivery Hero, Banco BPM, Lundin Ener..
11.11.OK boomer
11.11.MERCK KGAA : relèvement des objectifs annuels
11.11.EMEA MORNING BRIEFING : Stocks to Fall as Faster Fed Tightening More Likely
11.11.OK boomer
11.11.EN DIRECT DES MARCHES : ArcelorMittal, Engie, Beyond Meat, Siemens, Tesla, Sika...
11.11.Merck KgaA 3Q Earnings Fell Despite Sales Growth; Confirms Raised Guidance
11.11.Merck KGaA's lab supplies unit sees Q3 EBITDA jump 30.7%
11.11.Merck KGaA Ups FY21 Forecast Again Despite Lower Q3 Profit
11.11.MERCK Kommanditgesellschaft auf Aktien Reports Earnings Results for the Third Quarter a..
09.11.MARKETMIND : Melt up?
09.11.MARKETMIND : Calm after -- or before -- the storm
08.11.TAKE FIVE : Party time in Beijing
04.11.GLOBAL MARKETS LIVE : Electronic Arts, Credit Suisse, Novartis, Merck, Tesla...
04.11.CORONAVIRUS : Première autorisation pour la gélule de Merck, en Grande-Bretagne
04.11.LAS OPINIONES DE LOS ANALISTAS DEL D : Merck, Pfizer, Hugo Boss, BMW, Zalando, Pfizer, Nes..
04.11.Como una carta en el correo
04.11.Comme une lettre à la poste
04.11.Merck KGaA Lifts FY21 Targets Anew As Life Science Segment Soars
03.11.ADRs End Higher Wednesday, Merck and Suez SA Trade Actively
03.11.Merck KGaA raises 2021 profit forecast on lab supply demand
03.11.Merck KGaA lifts FY guidance on surging demand for lab supplies
03.11.Merck KGaA Raises 2021 Forecast on Strong 3Q
03.11.Merck KGaA Raises the Earnings Guidance for the Fiscal Year 2021
03.11.MARKETMIND : Judgement Day for the Fed
02.11.Merck KGaA Forms Independent Expert Committee for Sustainability
02.11.MARKETMIND : Aussie cbank caves in, who's next?
01.11.MARKETMIND : A week of central banks
29.10.MARKETMIND : Halloween scare on markets
28.10.MilliporeSigma Announces New Innovation & Capacity to Advance Next Generation Antibody-..
28.10.Merck Drives New Innovation & Adds Capacity to Advance Next Generation Antibody-Drug Co..
28.10.Siemens, Merck KGaA Plan Blockchain Technology Project
28.10.MARKETMIND : The ECB's inflation conundrum
27.10.Accord pour permettre un accès mondial de la pilule anti-Covid de Merck
26.10.MARKETMIND : Trillion-dollar Tesla
25.10.Xeris Pharmaceuticals Enters Collaboration Agreement With Merck
22.10.MERCK : Moody's Raises Merck KGaA's Rating to A3 on Improved Business Profile
21.10.MARKETMIND : Back to the blues
20.10.CytoReason Collaborates with Merck KGaA on Cancer Immunotherapy Drug
20.10.MARKETMIND : Margin pressures
19.10.MARKETMIND : Fast and furious
14.10.MERCK : EMD Serono, Inc. - New Real-World MAVENCLAD Data Show Sustained Effectiveness and ..
13.10.Merck KGaA's Multiple Sclerosis Treatment Drug Shows Improved Quality Of Life In Study
13.10.La energía se dispara, las acciones no tanto
12.10.MERCK : Opens Second Facility In California, US, With $115 Million Investment
12.10.MERCK : MilliporeSigma Announces Completion of New Viral Vector Contract Development Manuf..
06.10.MARKETMIND : Hunker down, it's going to be one of those days
06.10.CORRECTION : Merck KGaA Agrees to License CRISPR Technology to Genomics Group Cellecta
05.10.MERCK : Licenses CRISPR Technology To Genome Group Cellecta
1  2  3  4  5  6  7  8  9  10Weiter
Anstehende Termine für MERCK KGAA
03.03.22